Martin Hunt is Programme Director of NIHR Invention for Innovation (i4i), a translational funding programme.
Martin has over 30 years’ experience in the life science industry, with executive and Non-Executive Director (NED) roles in large multi-nationals, SMEs and public companies.
He was Chief Executive of Tissue Science Laboratories plc and led the company from angel funding as a start-up; a listing on the London Stock Exchange in 2001; through to the sale to Covidien in 2008. Since then, in addition to his Programme Director role for the NIHR, he has been Chair or NED on the Boards of nine early stage Medtech and Biotech companies. He is currently active on the boards of three companies, chairing two of these.
Martin has raised over £50m public / private funding to support innovative technologies and is an active business angel.